BUSINESSJul 3 · 15:08 UTCQUARTZCris Tolomia

Novo Nordisk is taking its new weight loss pill global

Novo Nordisk is launching its new weight loss pill in the United Arab Emirates as part of a global rollout. The company aims to regain market position against rival Eli Lilly in the weight loss drug sector.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Novo NordiskorganizationUnited Arab EmiratesplaceEli Lillyorganizationweight loss drug markettopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 18 · 05:00 UTC
Novo Nordisk’s next obesity battlefront: Winning beyond America
HEALTHJun 26 · 01:48 UTC
Insurance increasingly dropping weight loss drugs like Wegovy, Zepbound
HEALTHJun 7 · 23:35 UTC
The Wegovy pill is still dominating the GLP-1 pill market
BUSINESSMay 6 · 07:25 UTC
Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history
BUSINESSJun 3 · 08:05 UTC
Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
HEALTHJun 18 · 08:30 UTC
What’s next for GLP-1 weight loss drugs?